# 3-V Biosciences funding: rounds and investors > 3-V Biosciences has raised $146M across 8 rounds since 2007. Investors include New Enterprise Associates, Kleiner Perkins Caufield & Byers and The Column Group. Source: https://millionrounds.com/company/3-v-biosciences (Millionrounds; every figure on the page links to its filing or article) United States · [Series E startup](https://millionrounds.com/companies) # Who invested in *3-V Biosciences* 8 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Funding summary Updated 26 Oct 2026 **$146M** raised across 8 rounds since 2007, from 8 sources **$7.6M** Series A **$30M** Series B **$20M** Venture **$8.1M** Venture **$20M** Series C **$29M** Series D **$14M** Venture **$18M** Series E - **Latest round:** Series E, $18M Feb 2019 - **Biggest round:** $30M Series B · Jul 2009 - **Step-up i:** 1.3× - **Investors:** 6 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2007 2009 2011 2013 2015 2017 2019 **$7.6M** Series A **$30M** Series B **$20M** Venture **$8.1M** Venture **$20M** Series C **$29M** Series D **$14M** Venture **$18M** Series E - **First round:** Series A, $7.6M - **Biggest round:** $30M - **Usual gap between rounds:** 18 months ## The rounds - **Feb 2019** Series E **$18M** *1 new* [Ascletis](https://millionrounds.com/fund/ascletis) Reported by China Money Network SEC filing: $35M sold, first sale Feb 2019 - **Mar 2015** Venture **$14M** No investor was named in the report. From a historical funding record SEC filing: $14M sold, first sale Oct 2014 - **Dec 2014** Series D **$29M** *2 new* *2 returning* [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) [Rock Springs Capital](https://millionrounds.com/fund/rock-springs-capital) [Ally Bridge Group](https://millionrounds.com/fund/ally-bridge-group) From a historical funding record SEC filing: $14M sold, first sale Oct 2014 - **Jun 2013** Series C **$20M** *2 returning* [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) Reported by finsmes.com SEC filing: $7.5M sold, first sale Jun 2013 - **Oct 2012** Venture **$8.1M** *2 returning* [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) From a historical funding record SEC filing: $20M sold, first sale Nov 2011 - **Jan 2012** Venture **$20M** *2 returning* [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) Reported by finsmes.com SEC filing: $12M sold, first sale Nov 2011 - **Jul 2009** Series B **$30M** *3 new* [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) [The Column Group](https://millionrounds.com/fund/the-column-group) Reported by 3vbio.com SEC filing: $15M sold, first sale Jul 2009 - **May 2007** Series A **$7.6M** No investor was named in the report. From a historical funding record ## Founders and team From the SEC filings it signed: 2 on the team. - **Dennis Jason Hom** Executive Officer i - **George Kemble** Executive Officer, Director i On the board, as filed i *Beth Seidenberg* *David Mott* *Gordon Ringold* *James Young* *Jason Fuller* *Jinzi Jason Wu* *Merdad Parsey* *Richard Rodgers* *Xufang Jason Duan* ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series A** 2007 **Series B** 2009 **Venture** 2012 **Venture** 2012 **Series C** 2013 **Series D** 2014 **Venture** 2015 **Series E** 2019 [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) [The Column Group](https://millionrounds.com/fund/the-column-group) [Rock Springs Capital](https://millionrounds.com/fund/rock-springs-capital) [Ally Bridge Group](https://millionrounds.com/fund/ally-bridge-group) [Ascletis](https://millionrounds.com/fund/ascletis) ## Everyone who backed them [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) VC firm **5** rounds [Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) VC firm **5** rounds [The Column Group](https://millionrounds.com/fund/the-column-group) VC firm **1** round [Rock Springs Capital](https://millionrounds.com/fund/rock-springs-capital) Hedge fund **1** round [Ally Bridge Group](https://millionrounds.com/fund/ally-bridge-group) Private equity **1** round [Ascletis](https://millionrounds.com/fund/ascletis) Growth equity **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=3-v-biosciences). ## Quick answers about 3-V Biosciences ### Who invested in 3-V Biosciences? 3-V Biosciences's investors include New Enterprise Associates, Kleiner Perkins Caufield & Byers, The Column Group, Rock Springs Capital and Ally Bridge Group, and 1 more on record. ### How much has 3-V Biosciences raised? 3-V Biosciences has raised $146M across 8 rounds since 2007. ### When did 3-V Biosciences last raise? 3-V Biosciences's most recent round was a Series E of $18M in Feb 2019. ### What was 3-V Biosciences's biggest round? 3-V Biosciences's largest round on record is $30M (Series B), in Jul 2009. ### Who backed 3-V Biosciences first? 3-V Biosciences's first round on record, in Jul 2009, was backed by New Enterprise Associates, Kleiner Perkins Caufield & Byers and The Column Group. ### What stage is 3-V Biosciences at? 3-V Biosciences's latest named round is a Series E, in Feb 2019. ### Where is 3-V Biosciences based? 3-V Biosciences is based in the United States. ## Companies like 3-V Biosciences In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app